Gold Mitchell

Avg. Two Year Performance

(< 1%) Avg. Purchase Return
0% Compound
34% Avg. Sale Return
16% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return7%40%(24%)(37%)(< 1%)
Purchase Success Rate1 of 21 of 21 of 20 of 20 of 2
Average Sale Return12%26%22%(5%)34%
Sale Success Rate4 of 136 of 137 of 136 of 136 of 13
Drugs » Biotechnology

Executive Chairman and CEO, Director:

Holdings: 2.72M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 457.26K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--